Ramipril Supplier-Buyer Network — Trade Flow Analysis

Name: Ramipril Supplier-Buyer Trade Network Dataset — 177+ Indian Exporters, 25+ Importers, 93+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ramipril supplier network, Ramipril buyers, pharmaceutical export India, Ramipril trade data

TransData Nexus

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Who Supplies Ramipril? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Ramipril exporter from India, with a market share of 14.4% and a total export value of $12.9M across 320 shipments. Their average shipment value of $40.4K is above the market average of $18.0K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. CSP VIATRIS SANTE AT CSP- LAB, is the dominant customer, accounting for 57.7% of this supplier's tracked business. Top customers include:

• CSP VIATRIS SANTE AT CSP- LAB, — $7.5M across 185 shipments (57.7% of this supplier's total exports)

• CSP VIATRIS SANT? AT CSP- LAB — $3.7M across 92 shipments (28.8% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LAB, — $936.1K across 23 shipments (7.2% of this supplier's total exports)

• CSP VIATRIS SANTE AT CSP- LAB, — $428.6K across 11 shipments (3.3% of this supplier's total exports)

• CSP MYLAN SAS AT CSP — $382.2K across 9 shipments (3.0% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $40.4K is 124% above the market average of $18.0K, consistent with large-order contracts or value-added formulations.

2GENO PHARMACEUTICALS PRIVATE LIMITED

GENO PHARMACEUTICALS PRIVATE LIMITED is the second-largest Ramipril exporter from India, with a market share of 8.2% and a total export value of $7.4M across 686 shipments. Their average shipment value of $10.8K is below the market average of $18.0K, reflecting a high-volume, competitive pricing strategy.

GENO PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• M/S CRESCENT PHARMA LTD. — $2.5M across 233 shipments (34.0% of this supplier's total exports)

• CRESCENT PHARMA LIMITED — $1.5M across 143 shipments (20.9% of this supplier's total exports)

• CRESCENT PHARMA LTD — $1.5M across 142 shipments (20.7% of this supplier's total exports)

• M S CRESCENT PHARMA LIMITED — $1.1M across 106 shipments (15.4% of this supplier's total exports)

• M/S CRESCENT PHARMA LTD. — $674.2K across 63 shipments (9.1% of this supplier's total exports)

Key Insight: GENO PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (686 shipments) at a per-shipment value of $10.8K, indicating a broad distribution network with many smaller, regular orders.

3AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the third-largest Ramipril exporter from India, with a market share of 6.5% and a total export value of $5.8M across 811 shipments. Their average shipment value of $7.2K is below the market average of $18.0K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. MILPHARM LIMITED, is the dominant customer, accounting for 59.5% of this supplier's tracked business. Top customers include:

• MILPHARM LIMITED, — $3.5M across 483 shipments (59.5% of this supplier's total exports)

• RISING PHARMA HOLDINGS, INC. — $710.5K across 99 shipments (12.2% of this supplier's total exports)

• AUROLOGISTICS LLC (A — $642.7K across 90 shipments (11.0% of this supplier's total exports)

• APL SWIFT SERVICES (MALTA) LTD., — $592.2K across 83 shipments (10.2% of this supplier's total exports)

• GALENICUM HEALTH SL, — $410.4K across 57 shipments (7.0% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (811 shipments) at a per-shipment value of $7.2K, indicating a broad distribution network with many smaller, regular orders.

4IND SWIFT LIMITED

IND SWIFT LIMITED is the fourth-largest Ramipril exporter from India, with a market share of 6.0% and a total export value of $5.4M across 307 shipments. Their average shipment value of $17.7K is below the market average of $18.0K, reflecting a high-volume, competitive pricing strategy.

IND SWIFT LIMITED serves 5 named buyers in our database. WOCKHARDT UK LIMITED is the dominant customer, accounting for 87.6% of this supplier's tracked business. Top customers include:

• WOCKHARDT UK LIMITED — $4.8M across 269 shipments (87.6% of this supplier's total exports)

• ARROW PHARMACEUTICAL — $322.3K across 18 shipments (5.9% of this supplier's total exports)

• ARROW PHARMACEUTICAL — $208.9K across 12 shipments (3.9% of this supplier's total exports)

• APOTEX PTY LTD — $102.2K across 6 shipments (1.9% of this supplier's total exports)

• HEALTHCARE LOGISTICS — $38.5K across 2 shipments (0.7% of this supplier's total exports)

Key Insight: IND SWIFT LIMITED operates with high shipment frequency (307 shipments) at a per-shipment value of $17.7K, indicating a broad distribution network with many smaller, regular orders.

5SANOFI INDIA LIMITED

SANOFI INDIA LIMITED is the fifth-largest Ramipril exporter from India, with a market share of 4.1% and a total export value of $3.7M across 90 shipments. Their average shipment value of $40.6K is above the market average of $18.0K, suggesting premium or bulk contract pricing.

SANOFI INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SANOFI SAGLIK URUNLERI LTD STI — $1.7M across 41 shipments (45.2% of this supplier's total exports)

• SANOFI WINTHROP INDU — $743.3K across 18 shipments (20.3% of this supplier's total exports)

• SANOFI SRL — $541.6K across 13 shipments (14.8% of this supplier's total exports)

• SANOFI SAGLIK URUNLERI LTD STI — $483.0K across 12 shipments (13.2% of this supplier's total exports)

• SANOFI AVENTIS DEUTS — $234.5K across 6 shipments (6.4% of this supplier's total exports)

Key Insight: SANOFI INDIA LIMITED's per-shipment value of $40.6K is 125% above the market average of $18.0K, consistent with large-order contracts or value-added formulations.

6ZENTIVA PRIVATE LIMITED

ZENTIVA PRIVATE LIMITED is the fifth-largest Ramipril exporter from India, with a market share of 3.0% and a total export value of $2.7M across 233 shipments. Their average shipment value of $11.6K is below the market average of $18.0K, reflecting a high-volume, competitive pricing strategy.

ZENTIVA PRIVATE LIMITED serves 5 named buyers in our database. ZENTIVA ITALIA SRL is the dominant customer, accounting for 81.4% of this supplier's tracked business. Top customers include:

• ZENTIVA ITALIA SRL — $2.2M across 190 shipments (81.4% of this supplier's total exports)

• ZENTIVA FRANCE — $207.6K across 18 shipments (7.7% of this supplier's total exports)

• ALLOGA UK AP7 — $191.9K across 17 shipments (7.1% of this supplier's total exports)

• ZENTIVA PHARMA GMBH — $84.1K across 7 shipments (3.1% of this supplier's total exports)

• ZENTIVA, K.S. — $20.7K across 2 shipments (0.8% of this supplier's total exports)

Key Insight: ZENTIVA PRIVATE LIMITED operates with high shipment frequency (233 shipments) at a per-shipment value of $11.6K, indicating a broad distribution network with many smaller, regular orders.

1United Kingdom

United Kingdom ranks as the first-largest destination for Ramipril imports from India, with a total trade value of $31.4M across 1,063 shipments — representing a 35.0% share of all Ramipril exports. The average shipment value of $29.6K is above the global average of $18.0K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Ramipril importers in United Kingdom: WOCKHARDT UK LIMITED is the largest buyer, accounting for 21.3% ($6.7M) of this market's total imports.

• WOCKHARDT UK LIMITED — $6.7M (21.3% of United Kingdom's total)

• CRESCENT PHARMA LTD — $5.8M (18.3% of United Kingdom's total)

• BROWN AND BURK UK LIMITED — $4.0M (12.6% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $29.6K (64% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Ramipril imports from India.

Primary Market

Secondary Market

2France

France ranks as the second-largest destination for Ramipril imports from India, with a total trade value of $20.8M across 64 shipments — representing a 23.2% share of all Ramipril exports. The average shipment value of $324.8K is above the global average of $18.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ramipril importers in France: CSP VIATRIS SANTE AT CSP- LAB, is the largest buyer, accounting for 36.3% ($7.5M) of this market's total imports.

• CSP VIATRIS SANTE AT CSP- LAB, — $7.5M (36.3% of France's total)

• CSP VIATRIS SANT? AT CSP- LAB — $3.8M (18.3% of France's total)

Key Insight: France's per-shipment average of $324.8K (1701% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Ramipril imports from India.

Primary Market

Secondary Market

3United States

United States ranks as the third-largest destination for Ramipril imports from India, with a total trade value of $12.9M across 164 shipments — representing a 14.4% share of all Ramipril exports. The average shipment value of $78.7K is above the global average of $18.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Ramipril importers in United States: AUROLOGISTICS LLC, (AUROBINDO PHARM is the largest buyer, accounting for 11.3% ($1.5M) of this market's total imports.

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.5M (11.3% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES — $1.1M (8.2% of United States's total)

• RISING PHARMA HOLDINGS, INC. — $993.6K (7.7% of United States's total)

Key Insight: United States's per-shipment average of $78.7K (336% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Ramipril imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Ramipril imports from India, with a total trade value of $5.6M across 94 shipments — representing a 6.2% share of all Ramipril exports. The average shipment value of $59.2K is above the global average of $18.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ramipril importers in Canada: APOTEX INC, is the largest buyer, accounting for 32.8% ($1.8M) of this market's total imports.

• APOTEX INC, — $1.8M (32.8% of Canada's total)

• SUN PHARMA CANADA INC — $945.4K (17.0% of Canada's total)

Key Insight: Canada's per-shipment average of $59.2K (228% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Ramipril imports from India.

Primary Market

Secondary Market

5Italy

Italy ranks as the fifth-largest destination for Ramipril imports from India, with a total trade value of $4.4M across 169 shipments — representing a 4.9% share of all Ramipril exports. The average shipment value of $26.0K is above the global average of $18.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ramipril importers in Italy: ZENTIVA ITALIA SRL is the largest buyer, accounting for 87.4% ($3.8M) of this market's total imports.

• ZENTIVA ITALIA SRL — $3.8M (87.4% of Italy's total)

Key Insight: Italy's per-shipment average of $26.0K (44% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Italy is a key market for Ramipril imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ramipril.
2.Flow Mapping: 177 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,977 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 93 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4,977 Verified Shipments

177 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ramipril

Ramipril

Who Supplies Ramipril? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ramipril? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ramipril Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2GENO PHARMACEUTICALS PRIVATE LIMITED

3AUROBINDO PHARMA LTD

4IND SWIFT LIMITED

5SANOFI INDIA LIMITED

6ZENTIVA PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Ramipril Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ramipril Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

2France

3United States

4Canada

5Italy

People Also Ask — Ramipril Supplier & Trade Network

Ramipril Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology